Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
EMBO Rep ; 25(5): 2441-2478, 2024 May.
Article in English | MEDLINE | ID: mdl-38649663

ABSTRACT

Ago2 differentially regulates oncogenic and tumor-suppressive miRNAs in cancer cells. This discrepancy suggests a secondary event regulating Ago2/miRNA action in a context-dependent manner. We show here that a positive charge of Ago2 K212, that is preserved by SIR2-mediated Ago2 deacetylation in cancer cells, is responsible for the direct interaction between Ago2 and Caveolin-1 (CAV1). Through this interaction, CAV1 sequesters Ago2 on the plasma membranes and regulates miRNA-mediated translational repression in a compartment-dependent manner. Ago2/CAV1 interaction plays a role in miRNA-mediated mRNA suppression and in miRNA release via extracellular vesicles (EVs) from tumors into the circulation, which can be used as a biomarker of tumor progression. Increased Ago2/CAV1 interaction with tumor progression promotes aggressive cancer behaviors, including metastasis. Ago2/CAV1 interaction acts as a secondary event in miRNA-mediated suppression and increases the complexity of miRNA actions in cancer.


Subject(s)
Argonaute Proteins , Caveolin 1 , MicroRNAs , Neoplasm Metastasis , Argonaute Proteins/metabolism , Argonaute Proteins/genetics , MicroRNAs/metabolism , MicroRNAs/genetics , Caveolin 1/metabolism , Caveolin 1/genetics , Humans , Cell Line, Tumor , Animals , Gene Expression Regulation, Neoplastic , Extracellular Vesicles/metabolism , Mice , Protein Binding , Neoplasms/metabolism , Neoplasms/genetics , Neoplasms/pathology , Sirtuin 2/metabolism , Sirtuin 2/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...